Final efficacy and safety analysis of the CARIN phase III trial: Cap and Bev with or without Vin in 1st line metastatic breast cancer (MBC).

Welt, A., Marschner, N., Lerchenmüller, C., Decker, T., Salat, C., Busies, S., Hegewisch-Becker, S., 2014.

Ann Oncol, ESMO (Madrid) 25, iv119 (359PD). doi:10.1093/annonc/mdu329.9

Studie: CARIN; Indikation: Mammakarzinom; Jahr: 2014; Veranstaltung: ESMO; Journal: Annals of Oncology

Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0